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Background: Both mental and somatic symptoms are commonly reported in patients with stress-related problems.
We have explored the prevalence of somatic symptoms in patients seeking medical care for stress-related mental
health problems and followed the course of illnes alongside with that the patients receive multimodal treatment.
Method: This study comprises data from 228 patients (69% women, mean age 43 years) who fulfilled the criteria
for Exhaustion Disorder (ED). Somatic symptoms were assessed at baseline and after 3, 6, 12 and 18 months using
the one-page questionnaire Primary Care Evaluation of Mental Disorders. Prevalence of different symptoms was
compared between men and women and patients, over and below 40 years of age, and possible predictors of
recovery were explored.
Results: Tiredness and low energy are the core symptom reported by the patients. Almost all (98%) reported at
least one somatic symptom and 45% reported six symptoms or more, which was similar for men and women.
Nausea, gas or indigestion are the most common symptoms (67%) followed by headaches (65%) and dizziness
(57%). The number of symptoms reported was significantly related to the severity of mental health problems. The
only difference between the sexes was that “chest pain” and “pain or problems during sexual intercourse” were
more common among males. Patients over forty more often reported “pain in arms, legs or joints, knees, hips” and
this was also the only symptom that did not significantly decline during treatment. Neither sex, age, symptom
duration before seeking medical care, education or any other predictor tested was shown to predict recovery in
patients reporting six symptoms or more.
Conclusion: A heavy burden of somatic symptoms was generally seen in most patients with stress-related exhaustion.
Somatic symptoms are equally common in males and females and in younger and older patients. The somatic symptoms
seem to be mostly stress-related since all symptoms, except musculoskeletal pain, reduce with individualised treatment
designed for stress-related mental problems. This study brings to attention the complicated burden of both somatic and
mental symptoms in patients with stress-related exhaustion, raising several clinical implications of interest to discuss.
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It is well known that chronic stress exposure can result
in clinical symptoms and complaints, often referred to
as stress-related disorders [1,2]. The term “stress-related
disorder” has not been clearly defined, but is most com-
monly used to describe mental health problems mainly
caused by psychosocial stress, such as fatigue, burnout,
exhaustion, depression or adjustment disorder. Studies
using the burnout concept are numerous in the litera-
ture and it is commonly defined as a mental condition
that has developed as a result of continuous stress
exposure particularly related to psychosocial factors at
work [3]. The theoretical basis behind the available self-
report instruments constructed to assess burnout differs.
Attempts have been made to adapt the burnout concept
to be more usable in clinical practice. In the
Netherlands, clinical burnout as diagnosis has been sug-
gested, using the diagnostic criteria of neurasthenia and
adding the component that the problem should be
work-related [4,5]. We have also recently suggested a
cut-off for clinical burnout when using the Shirom-
Melamed Burnout questionnaire (SMBQ) [6]. The clin-
ical diagnosis “Exhaustion disorder” (ED) has been pro-
posed by the National Board of Health and Welfare in
Sweden to be used in clinical practice. ED defines
patients with exhaustion that has developed as a conse-
quence of identifiable stressor(s) that have been present
for at least six months. The symptoms of ED and burn-
out are closely related, and we have previously shown
that the majority of patients fulfilling the diagnostic cri-
teria for ED can also be described as burned-out [7,8].
We have also recently shown that patients with ED do
report both work-related and non-work related stressors
as a plausible cause of the stress-related exhaustion. This
supports the use of clinical diagnosis that does not only
consider work-related stress exposure [9].
Persons seeking medical care mainly for stress-related
exhaustion often report co-morbid depression and/or
anxiety and consequently their mental burden of illness
is high [10-13]. The relationship between mental and
somatic symptoms is well recognized both from clinical
experience and from the literature [14,15] and thus we
expect the occurrence of somatic symptoms to be high
in these patients. Several previous studies have shown
that the prevalence of somatic symptoms is higher in
primary care patients with depressive disorder than in
patients not reporting any mental disorder [14,15]. Hav-
ing multiple somatic symptoms has been shown to be a
strong predictor of mental health problems such as de-
pression and anxiety [16]. Somatisation disorder, which
is as a tendency to experience and communicate somatic
distress rather than cognitive response to psychosocial
stress and to seek medical help for it, this condition is
also often combined with mental health problems [17].A high prevalence of somatic symptoms in patients
with stress-related exhaustion could also be expected
due to the fact that a high level of perceived stress is
known to be related to many different somatic symp-
toms such as headache [18,19], gastrointestinal problems
[20,21], palpitation [22] and musculoskeletal and joint
pain [23]. Physical illness is more common among sub-
ject with burnout than others [24] and several studies
have shown that burnout in working populations is re-
lated to increased level of different somatic symptoms
such as gastrointestinal and cardiovascular symptoms
[25] and neck and back pain [25,26] as well as to the
general level of somatic complaints [27]. Few studies are
available studying prevalence of somatic symptoms in a
clinical population of patients suffering from exhaus-
tion/clinical burnout and we are not aware of any study
that have followed the course of symptoms for a longer
period of time. One interesting aspect when studying
symptoms and the burden of illness is sex differences.
Women consistently report higher prevalence of somatic
symptoms, particularly musculoskeletal pain, compared
to men [28,29], and mental disorders such as depression
and anxiety are more prevalent among women [30-32].
Burnout, mainly studied in working populations has in
many studies been seen to be more common among
women compared to men [33,34], while other studies
have not seen any difference in prevalence of burnout
between women and men [35]. Interestingly, we recently
showed in a clinical patient population diagnosed with
exhaustion that men and women did not differ regarding
the burden of mental symptoms, measured as burnout,
depression and anxiety [8]. Thus, the sex difference
commonly seen for the prevalence of mental health
problems does not seem to be reflected in the burden of
symptoms in a clinical patient population [8].
In this study, we wanted explore the burden of somatic
symptoms in a clinical patient population with stress-
related exhaustion, and to explore the prevalence of
several different symptoms. We hypothesize that both
female and male patients would report a substantial
number of somatic symptoms. Kroenke and co-workers
(1998) showed that the sex difference, with women gener-
ally reporting higher levels of symptoms, was independent
of psychiatric co-morbidity, measured as depression and/
or anxiety [29]. A similar finding was reported by Haug
and co-workers showing that women report a higher mean
number of somatic symptoms than men irrespective of
depression or anxiety diagnosis [36]. Given this, one could
expect higher burden of somatic symptoms in women
compared to men with stress-related exhaustion. The pri-
mary aim of the present study was to study the prevalence
of somatic symptoms in patients with stress-related
exhaustion and to follow the course of symptoms during
18 months alongside with that the patient receive
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plore if female and male patients, as well as younger and
older patients, differ regarding the prevalence of somatic
symptoms and course of symptoms over time. Baseline
data collected at the first visit regarding socio-demographic
factors, co-morbidity, duration of symptoms before seeking
medical care, and use of antidepressant medication, were
also evaluated as possible predictors of recovery in terms




The present study comprises data from 228 patients,
156 (69%) women and 72 (31%) men. All had been re-
ferred from Primary Health Care or Occupational Health
Service Centres between 2004 and 2010 to a specialist
clinic in western Sweden exclusively treating patients
with stress-related mental disorders. The referral criteria
were stress-related exhaustion with no apparent somaticTable 1 Baseline characteristics of patients with stress-related
N Total n (%) Wo
Marital status 228
– Married 171 (75)
– Single or other 57 (25)
Education1 219
– higher 157 (72)
– lower 62 (28)
Duration of symptoms2 219
– <1 year 93 (43)
– ≥1 year 126 (58)
Co-morbid depression3 228
– Yes 175 (77)
– No 53 (23)
Co-morbid anxiety3 228
– Yes 185 (81)
– No 43 (19)
SMBQ4 192
– <4 12 (6)
– ≥4 180 (94)
HAD depression5 214
– <10 140 (65)
–≥ 11 74 (35)
HAD anxiety5 213
– <10 81 (38)
–≥ 11 132 (62)
1Higher education is one year of college or more 2 Self-reported duration of sympto
score of the Shirom Melamed Burnout Questionnaire, 5Total score on the respective
6p-value: Pearson’s Chi Square test was used to compare women and men.disorder or abuse that could explain the exhaustion, and
a maximal duration of sick leave of six months. All pa-
tients were ambulatory at the time of the study and none
had received in-patient care due to their illness. Seventy-
eight percent was on full-time or part-time sick leave.
The mean age for the group was 43.3 years (SD 9.3;
range 24–63), with no difference between women (43.7;
SD 9.7) and men (42.3; SD 8.4). When analysing possible
age-related differences among the patients, we split into
younger (24–39 years; n = 82) and older (40–63 years;
n = 146). Baseline characteristics for the patients are
shown in Table 1.
Inclusion criteria
Only patients fulfilling the diagnostic criteria for Exhaus-
tion Disorder (Table 2) were included in this study. Co-
morbidity of depression and/or anxiety was allowed and
screened for. Patients with somatic disorders, such as
generalised pain, thyroid disease, vitamin B-12 deficiency
or obesity, which might explain the exhaustion, wereExhaustion Disorder (ED)
men (n = 156) n (%) Men (n = 72) n (%) p-value6
119 (76) 52 (72) 0.510
37 (24) 20 (28)
116 (76) 41 (62) 0.039
37 (24) 25 (36)
62 (42) 31 (44) 0.709
87 (58) 39 (56)
117 (75) 58 (81) 0.356
39 (25) 14 (19)
121 (78) 64 (89) 0.042
35 (22) 8 (11)
8 (6) 4 (7) 0.936
122 (94) 58 (94)
102 (69) 38 (59) 0.157
47 (32) 27 (42)
56 (37) 25 (40) 0.747
94 (63) 38 (60)
ms before seeking medical care for exhaustion, 3Clinical diagnosis, 4Mean total
subscale of the Hospital Anxiety and Depression Scale.
Table 2 Diagnostic criteria for stress-related Exhaustion
Disorder as proposed by the Swedish National Board of
Health and Welfare
Diagnostic criteria for exhaustion disorders
A Physical and mental symptoms of exhaustion with a minimum of
two weeks duration. The symptoms have developed in response to
one or more identifiable stressors which have been present for at
least 6 months.
B Markedly reduced mental energy, which is manifested by reduced
initiative, lack of endurance, or increase of time needed for recovery
after mental efforts.
C At least four of the following symptoms have been present most of
the day, nearly every day, during the same 2-week period:
1 Persistent complaints of impaired memory.
2 Markedly reduced capacity to tolerate demands or to work under
time pressure.
3 Emotional instability or irritability.
4 Insomnia or hypersomnia.
5 Persistent complaints of physical weakness or fatigue.
6 Physical symptoms such as muscular pain, chest pain, palpitations,
gastrointestinal problems, vertigo or increased sensitivity to sounds.
D The symptoms cause clinically significant distress or impairment in
social, occupational or other important areas of functioning.
E The symptoms are not due to the direct physiological effects of a
substance (e.g. a drug of abuse, a medication) or a general medical
condition (e.g. hypothyroidism, diabetes, infectious disease).
F The stress-related disorder does not meet the criteria for major
depressive disorder, dysthymic disorder or generalized anxiety
disorder.
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tients with alcohol abuse or serious psychiatric diagnoses
other than depression and anxiety. Blood samples were
taken for the purpose of differential diagnosis.
Diagnostic procedures
Three senior physicians carried out a diagnostic procedure,
obtaining an extended anamnesis and performing a phys-
ical examination. The diagnostic procedure for ED has
been previously described in detail [8]. If the patient meet
the criteria for major depressive disorder, dysthymic
disorder or generalised anxiety disorder, these diagnoses
are set first and ED is set as a co-morbid condition. The
assessment of depression and anxiety was standardized by
using the Primary Care Evaluation of Mental Disorders
(PRIME-MD) instrument [37]. Before consulting the phys-
ician the patients filled in the one-page PRIME-MD pa-
tient questionnaire that covers questions on both somatic
as well as mental symptoms. Positive responses were
followed up by the physician in a structured interview
based on the PRIME-MD manual, conforming with the
DSM IV criteria [37], for diagnostic assessment of depres-
sion and anxiety disorder. General anxiety, unspecific
anxiety and/or panic disorders were classified as anyanxiety disorder. During both referral and diagnostic pro-
cedures, special attention was paid to diagnostic criteria of
chronic fatigue syndrome [38], and fibromyalgia [39],
which share many symptoms with ED. Patients who fulfil
the criteria for these diagnoses were referred to other
clinics and thus data from such patients were not included
in this study.
All patients thus fulfilled the diagnostic criteria of ED
at baseline. Nine percent were diagnosed with ED alone
and 10% also fulfilled the criteria for depression as a
co-morbid condition, 15% for any anxiety disorder as a
co-morbid condition and 67% for both depression and
any anxiety disorder as co-morbid with ED (Table 1).
The prevalence of co-morbid depression did not differ
between women and men or between younger (73%)
and older (79%) patients but men reported more co-
morbid anxiety than women (Table 1), as did younger
(89%) compared to older patients (77%) (p = 0.023).
Procedures
Data analysed in this study is registry data from a patient
registry that has been collected during several years at
the specialist clinic. The data used in this study was col-
lected during the first visit at the clinic and then at follow-
ups after 3, 6, 12 and 18 months. During this period all pa-
tients received multimodal treatment (MMT). All patients
receive similar treatment and the content of the MMT
treatment has been described in more detail previously
[8]. When entering the treatment programme, 28% (n = 64)
of the patients were already on antidepressants (ADs)
and as a large number of the patients were clinically
judged to be in need of such medication as many as 60%
(n = 136) were on antidepressants after the 3-month
follow-up. At the 18-month follow-up 53% (n = 121)
were still on antidepressants. Frequent communication
with the Social Insurance Office and the employer re-
garding sick leave was maintained, aiming for the earliest
possible return to work.
Measurements
Bivariate analysis was performed for each of the follow-
ing baseline variables as possible predictors of recovery:
clinical depression (yes or no), any anxiety disorder (yes or
no), combined co-morbidity (ED or ED and depression,
ED and any anxiety or ED combined with depression and
any anxiety), marital status (married or “single or other”),
sick leave (no sick leave, part-time or full-time sick leave),
self-reported physical activity (sedentary lifestyle, light or
“moderate physical activity or moderate to vigorous phys-
ical training”), use of ADs (yes or no), symptom duration
and level of education. The level of education was defined
as high if the person had completed one year of college
education or more. Symptom duration was measured by
asking the patients to estimate for how many years, before
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that they were seeking care for. Symptom duration was
dichotomised into less than one year or more than a year.
All data mentioned above was collected before the first
visit to the clinic, using a postal questionnaire that all
patients entering the treatment programme at the clinic
were asked to fill in before their first visit.
The questionnaires regarding somatic symptoms, burn-
out, depression and anxiety, described below, were filled
in by the patients at baseline and then during follow-up at
3, 6, 12 and 18 months.
Somatic symptoms
The PRIME MD short patient form includes 16 ques-
tions on commonly reported symptoms in primary care
patient populations: stomach pain, back pain, pain in
arms, legs or joints (knees and hips included), menstrual
pain or problems, pain or other problems during sexual
intercourse, headache, chest pain, dizziness, fainting
spells, feeling your heart pound or race (i.e. palpitation),
shortness of breath, constipation, loose bowels or diar-
rhoea, nausea, gas or indigestion, feeling tired or having
low energy, trouble sleeping, and eating being out of
control. The patients were asked to answer yes or no to
each question depending on whether the symptom had
occurred often during the past month. The patients were
then asked to fill out the same form at each follow-up.
The symptoms “feeling tired or having low energy”,
“trouble sleeping” or “eating being out of control” are
rather considered as measures of mental symptoms and
were thus excluded in this analysis of somatic symptoms.
Two of these symptoms are also considered as cardinal
symptoms of these patients, as 98% reported that they
felt tired or had low energy and 85% reported that they
had trouble sleeping.
Menstrual symptoms were also excluded from the ana-
lysis since one of the main aims of this study was to com-
pare males and females. The remaining 12 symptoms
were selected to represent the somatic burden of disease
in patients with ED.
Burnout and symptoms of depression and anxiety
The Shirom-Melamed Burnout Questionnaire (SMBQ)
was used to measure symptom of burnout [40]. A mean
score above 3.75 on SMBQ total score has been used as
a cut-off to define high burnout based on quartile splits
[41], and Stenlund and co-workers reported the mean
score of the total scale in patients with clinical burnout
to be 5.7 for women and 5.6 for men [42]. In the present
study, a total mean score of ≥ 4.0 was used as a cut-off
for burnout as it was used in our previous paper of a
similar patient population [8]. This score is close to the
cut-off point of ≥4.4 that our research group has sug-
gested as the cut-off to be used as an indication ofclinical burnout [6]. Since ED and burnout are closely
related conditions, we expected almost all patients to
score above this cut-off. The widely used Hospital Anxiety
and Depression scale (HAD) was employed to assess self-
reported symptoms of depression and anxiety. This scale
was originally developed for non-psychiatric clinics to
detect states of depression and anxiety [43]. A sum score
above 10 was used to indicate probable depression and
anxiety, respectively. Cronbach’s alpha for the total SMBQ
was found to be 0.91, for HAD subscale anxiety 0.82 and
for HAD subscale depression 0.81.
Statistical analysis
Pearson’s Chi-Square test was used to compare men and
women regarding baseline characteristics, except for age
where Student’s t-test was used. The prevalence of
symptoms during each follow-up was compared be-
tween men and women and the two different age
groups (24–39 and 40–63 years) respectively by using
Pearson’s Chi-Square test.
Somatic symptoms were analysed in three ways 1) as
mean number and standard deviation (SD) of symptoms
at each time point during the follow-up, 2) as a dichot-
omous variable where a total of 6 symptoms or more
was set as cut-off level indicating a heavy burden of
somatic symptoms, and 3) as prevalence of each symp-
tom at baseline and during follow-up.
The cut-off of 6 symptoms and more was chosen
according to Kroenke and co-workers that showed in pri-
mary care patients that there was a powerful relationship
between the number of somatic symptoms and the likeli-
hood of a mental disorder. At this particular burden of
somatic symptoms 6 or more, referred to as multiple som-
atic symptoms, the likelihood of anxiety or depressive
disorder was more than half of the population [15,44].
When analysed as mean number of symptoms, the
non-parametric Mann–Whitney Test was used to compare
different groups (men and women, younger and older) as
the data was not normally distributed. The Mann–Whitney
Test was also used to compare mean somatic symptoms in
patients scoring over and under the median cut (5.45) on
SMBQ. The non-parametric Wilcoxon’s signed rank test
was used to test for significant changes in mean somatic
symptoms between the measurement points. Comparing
the prevalence of somatic symptoms using the HAD
subscales, the cut-off 11 or more was used for both.
When somatic symptoms were treated as a dichotomous
variable, the non-parametric Cochran’s Q test was used for
testing change over time in the proportion of patients who
scored above the cut-off level of six symptoms or more.
McNemar’s test was then used for group-wise comparisons
between two measurement points.
Cox’s regression with constant time at risk was used in
bivariate analyses to identify possible predictors of recovery
Glise et al. BMC Psychiatry 2014, 14:118 Page 6 of 13
http://www.biomedcentral.com/1471-244X/14/118measured as scoring <6 somatic symptoms, at the follow-
ups after 6, 12 and 18 months among patients who reported
more than six somatic symptoms at baseline. Results were
expressed as a prevalence ratio (RR) with 95% confidence
intervals. The bivariate analyses were performed for each of
the following baseline variables: clinical depression, any anx-
iety disorder, combined co-morbidity, marital status, symp-
tom duration, sick leave, level of education, physical activity
and use of ADs.
The level of significance was set as p < 0.05. The statis-
tical package SPSS Statistics 19 was used for all statistical
analyses.
Ethics
The study was approved by the regional ethical review
board in Gothenburg, Sweden and conducted according
to the 1964 Helsinki Declaration. Only patients who
consented to the use of their clinical data for research
purposes were included.
Result
Prevalence of somatic symptoms
The mean number of symptoms reported by the patients
at baseline was 5.3 (SD 2.4). This did not differ signifi-
cantly between women (mean 5.3; SD 2.4) and men (mean
5.3; SD 2.6) (p = 0.790) or between younger (mean 5.2; SD
2.5) and older patients (mean 5.3; SD 2.4) (p = 0.798). Four
patients (2%) reported no somatic symptoms; 26 patients
(11%) reported one or two symptoms, 96 patients (42%)
reported three to five symptoms and 102 patients (45%)Table 3 Percentage of women and men with Exhaustion Diso
at the first visit to the stress clinic that they have frequently
month
Symptom Total group
(N = 228) %
(n)
Nausea, gas or indigestion 67 (153)
Headaches 65 (149)
Dizziness 57 (129)
Constipation, loose bowels, or diarrhoea 54 (123)
Feeling heart pound or race 54 (122)
Back pain 51 (116)
Chest pain 47 (106)
Pain in arms, legs or joints, knees, hips 49 (111)
Stomach pain 45 (103)
Shortness of breath 23 (52)
Pain or problems during sexual intercourse 14 (31)
Fainting spells 4 (8)
*PRIME-MD = Primary Care Evaluation of Mental Disorders.
1p-value: Pearson’s Chi-Square test was used to compare the prevalence of the sing
the difference between the sexes is statistically significant (p < 0.05).reported six symptoms or more. The proportion reporting
six or more symptoms was similar among males (42%)
and females (46%) as well as among younger and older
patients (both 45%).
Among the 12 somatic symptoms analysed in this
study, problems with gas or indigestion were the most
common symptoms reported (67%), followed by head-
aches and dizziness (Table 3). There were no differences
in the prevalence of the different somatic symptoms
between males and females, except that chest pain and
pain or problems during sexual intercourse were signifi-
cantly more common among men (Table 3). The only
difference seen between older and younger patients was
that pain in the arms, legs or joints was more common
in the older patients. There was also an indication that
problems during sexual intercourse might be more com-
mon in younger than older patients, but this difference
did not reach statistical significance (Table 4).
Course of somatic symptoms
A successive decrease in the mean number of somatic
symptoms was seen for the total group at each follow-up;
baseline 5.3 (SD 2.4), three months 4.0 (SD 2.6) (p <
0.0005), six months 3.7 (SD 2.5) (p = 0.006), 12 months
3.3 (SD 2.3) (p = 0.012) and 18 months 3.1 (SD 2.5) (p =
0.028). A similar pattern was seen for both sexes, but the
decrease between 3 and 6 months did not reach statistical
significance in either women or men (data not shown).
Also, the decrease in the number of symptoms among
women between 12 (mean 3.5; SD 2.3) and 18 monthsrder (ED) reporting on the PRIME-MD* symptoms checklist
experienced the respective symptom during the past
Women Men p-value1
(n = 156) (n = 72)
% (n) % (n)
69 (108) 63 (45) 0.315
64 (99) 69 (50) 0.378
l60 (94) 49 (35) 0.099
54 (84) 54 (39) 0.964
57 (89) 46 (33) 0.114
49 (76) 56 (40) 0.337
42 (65) 57 (41) 0.032
52 (81) 42 (30) 0.150
47 (74) 40 (29) 0.313
22 (34) 25 (18) 0.592
10 (16) 21 (15) 0.030
3 (5) 4 (3) 0.714
le somatic symptoms between women and men. Bold numbers indicate that
Table 4 Percentage of younger (24–39 years) and older (40–63 years) patients with Exhaustion Disorder (ED) reporting
on the PRIME-MD* symptoms checklist at the first visit to the stress clinic that they have frequently experienced the
respective symptom during the past month
Symptom Total group Younger1 Older2 p-value3
(N = 228) (n = 82) (n = 146)
% (n) % (n) % (n)
Nausea, gas or indigestion 67 (153) 62 (51) 70 (102) 0.237
Headaches 65 (149) 72 (59) 62 (90) 0.117
Dizziness 57 (129) 49 (40) 61 (89) 0.075
Constipation, loose bowels, or diarrhea 54 (123) 54 (44) 54 (79) 0.948
Feeling heart pound or race 54 (122) 49 (40) 56 (82) 0.283
Back pain 51 (116) 52 (43) 50 (73) 0.724
Chest pain 47 (106) 51 (42) 44 (64) 0.283
Pain in arms, legs or joints, knees, hips 49 (111) 33 (27) 58 (84) <0.001
Stomach pain 45 (103) 48 (39) 44 (69) 0.558
Shortness of breath 23 (52) 24 (20) 22 (32) 0.669
Pain or problems during sexual intercourse 14 (31) 20 (16) 10 (15) 0.051
Fainting spells 4 (8) 5 (4) 3 (4) 0.400
1Younger: 24–39 years.
2Older: 40–63 years.
3p-value: Pearson’s Chi-Square test was used to compare the prevalence of the single somatic symptoms between younger and older patients. Bold numbers
indicate that the difference between the age groups is statistically significant (p < 0.05).


























Figure 1 Proportion of women and men reporting six symptoms
or more at baseline and at follow-ups after 3, 6, 12 and
18 months. *Indicates that the difference between two time points is
statistically significant (p < 0.05).
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final follow-up, 18 months after onset of treatment, men
reported a mean of 2.5 (SD 2.4) somatic symptoms and
this was the only time point showing a statistically signifi-
cant sex difference, with women reporting a mean of 3.3
(SD 2.6) (p = 0.024). There were no clear differences in
this respect when comparing younger and older patients.
The proportion of patients reporting six symptoms or
more declined from baseline (45%) to follow-up at
18 months (20%) (p < 0.0005). Most of this reduction in
symptoms occurred during the first three months. The
pattern was similar for women and men (Figure 1), as
well as for younger and older patients.
The course of single symptom
The prevalence of all 12 somatic symptoms assessed in
this study decreased between baseline and the final
follow-up at 18 months, except for pain in arms, legs or
joints (p = 0.401), and fainting spells (due to the small
number of cases). Thus, neither in women nor in men
was there a significant decline in the prevalence of pain
in arms, legs or joints. Similarly, sexual problems were
more often reported by men at baseline (21%) than by
women (10%), but at follow-up only 4% of the men still had
such problems (p < 0.0005) with no difference between the
sexes. The course of somatic symptoms was similar among
younger and older patients, with one exception showing
that pain in arms, legs or joints was significantly more
common in older patients (58%) compared to younger(33%) (p < 0.0005) at baseline. This difference between
older and younger was present during the course of all
measurement points (data not shown). The development
of the respective symptoms over 18 months is shown in
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Figure 2 Course of somatic symptoms. A. Course of symptoms
from the chest and dizziness during 18 months follow-up in male
and female patients with stress-related exhaustion. The only significant
difference seen was that chest pain was more common among men
(57%) than women (42%) at baseline (p = 0.032). B. Course of
gastrointestinal symptoms during 18 months of follow-up in male and
female patients with stress-related exhaustion. The only significant
difference seen was that stomach pain was more frequently reported
among women (31%) than men (18%) (p = 0.035). C. Course of
pain-related symptoms during 18 months in male and female patients.
At 12 months pain in arms, legs or joints was more common among
women (48%) than men (32%) (p = 0.022).
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depression and anxiety
Patients scoring above the median of 5.45 on the burn-
out scale SMBQ (n = 105) reported a significantly higher
number of somatic symptoms (mean 6.1; SD 2.5) than
patients with lower scores (n = 115) (mean 4.5; SD 2.1)
(p < 0.0005). Similarly, when the patients were split into
two groups with cut-off 11 or more on the HAD scale,
patients scoring above the cut-off for symptoms of
depression (n = 74) reported more somatic symptoms
(mean 6.0; SD 2.5) than those scoring below (n = 140)
(mean 4.9; SD 2.3) (p = 0.002). High anxiety levels
(n = 132) was also associated with a higher number
of somatic symptoms (5.9; SD 2.5) when compared with
patients with lower scores (n = 81), (mean 4.4; SD 2.1)
(p < 0.0005).
Predictors of recovery
All patients with complete data who reported six or
more symptoms at baseline (n = 102) were included in
the analysis regarding possible predictors (level of educa-
tion, marital status, symptom duration before seeking med-
ical care, co-morbidity of depression and/or anxiety, use of
ADs, sick leave and physical activity) of having less than six
symptoms at follow-up. None of the variables tested were
found to predict recovery at any of the follow-ups. Data
from the 12-month follow-up are shown in Table 5 and
similar results were found for other time points.
Discussion
The main findings from this study are that patients seek-
ing medical care mainly for stress-related exhaustion,
also report a numerous different somatic complaints.
Thus, almost half of the participants reported six somatic
symptoms or more at the first consultation. Concomi-
tantly to that the patients are receiving treatment for the
exhaustion, most of the somatic symptoms decline. Nei-
ther number of somatic symptoms or changes in number
symptoms reported over time differ between men and
women or between younger and older patients.
It is well known from the literature that somatic symp-
toms are closely related to mental symptoms both in
Table 5 Results from Cox’s regression analyses of
possible predictors of reporting less than six somatic
symptoms at 12-month follow-up in patients with
Exhaustion Disorder who reported six symptoms or
more at baseline (N = 102)
N RR (95% CI)
Sex
- Men 30 1
- Women 72 1.01 (0.59-1.72)
Age
- 18-39 37 1
- 40-64 65 0.85 (0.52-1.40)
Co-morbid depression
- No 18 1
- Yes 84 0.66 (0.37-1.15)
Co-morbid anxiety disorder
- No 12 1
- Yes 90 0.73 (0.37-1.44)
Marital status
- Married 76 1
- Single or other 26 0.80 (0.44-1.45)
Symptom duration
- less than a year 37 1
- one year or more 61 0.74 (0.45-1.22)
Sick leave
- No 29 1
- Part time 16 1.39 (0.67-2.85)
- Full time 57 1.05 (0.59-1.87)
Education, college or more
- Yes 60 1
- No 28 1.36 (0.79-2.36)
Physical activity
- Sedentary lifestyle 27 1
- Light physical activity 50 1.05 (0.58-1.89)
- Moderate or intense physical activity 22 0.87 (0.41-1.81)
Risk ratio (RR) and 95 % confidence interval (CI).
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[15,45]. This study has focused on a specific patient
population that seeks medical care mainly for stress-
related mental symptoms and it is thus expected that
the symptoms that were reported by the patients in this
study are strongly related to psychosocial stress [1]. The
interesting finding is, however, that female and male
patients do not differ regarding the burden of somatic
symptoms, which resembles the findings from our previ-
ous study measuring mental symptoms [6]. Thus, these
results differ from what is usually seen in primary care
populations, i.e. that women report a heavier burden ofsymptoms. The PRIME-MD 1000 study in primary care
showed that women more commonly reported as many
as 10 out of 13 somatic symptoms to be prevalent
during the preceding months [29]. A Swedish study in
primary care showed that women report more somatic
symptoms during the preceding 3 months than men
[46]. Furthermore, the HUNT-II study covering all in-
habitants in one region in Norway more than 20 years of
age showed that women compared with men report
more somatic symptoms during the preceding year [36].
One may speculate that sex differences commonly seen
with regard to both mental and somatic symptoms van-
ish when the health problems reach such a severe level
as is the case for the patients included in this study.
Concerning specific symptoms the only difference seen
between the sexes in the present study was a higher
prevalence of chest pain and pain or problems during
sexual intercourse among males. In line with this present
study stress at work was associated with an almost four-
fold increase in the risk for unexplained chest pain
among men, whereas this was not seen among women
[47], and burnout has previously been shown to risk fac-
tor for cardiovascular health problems among men while
the evidence is unclear in women [24,48]. This symptom
does decline with time, concomitantly as the patients are
being treated to their stress problems, and no difference
was seen between the sexes during the last follow-up
18 months later. This supports the hypothesis that the
origin of the chest pain in this group of patients is
stress-related and that men report this symptom more
frequently than women when experiencing stress. In line
with our finding, pain or other problems during sexual
intercourse was the only symptom noted to be more
common among men than women in a patient popula-
tion seeking primary care [29]. This is a rare symptom
but should be taken into consideration since it was
reported by more than one fifth of the men and most
probably reduces quality of life substantially. Fortunately,
it seems that the treatment offered at the clinic suc-
ceeded in influencing this clinical problem since only
four per cent of the male patients reported this to be a
problem at 18-month follow-up. We do not, however,
know if they had been seeking treatment elsewhere for
this problem, which is a limitation when drawing a con-
clusion regarding the reason for symptom reduction.
There was no difference in the average number of
somatic symptoms between younger and older patients:
earlier studies on primary care populations showed di-
vergent results for somatic symptoms and association
with age [46,49]. Only one symptom was found to differ
between the groups, showing that older patient more
commonly report pain in arms legs and joints. It has
been shown that the prevalence of somatic symptoms
increases with age in general population [36], but this
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related exhaustion. One may speculate that a similar
explanation could be offered as in the discussion about
sex differences above, i.e. potential differences regarding
both mental and somatic symptoms vanish when the
health problems reach such a severe level as is the case
for the patients included in this study. Thus, even pa-
tients still only in their twenties report a similar burden
of symptoms as patients in their sixties and consequently
the burden of somatic symptoms even among young
patients with exhaustion might be expected to be high.
Pain in arms legs and joints in older has to be specially
considered to offer adequate treatment.
The most prevalent symptoms in this study are com-
monly regarded as being stress-related and a recent review
confirms that this is the case for e.g. gastrointestinal prob-
lems, dizziness, headaches and back pain [1]. In fact, many
of the patients referred to the clinic report during the clin-
ical interview that they had earlier been seeking medical
help for one or more of their somatic symptoms without
recognition of the underlying stress exposure and associ-
ated mental health problems. In primary care it is com-
mon that patients seek help for a single symptom, even
though they are in fact suffering from several other mental
and/or somatic symptoms [49]. This indicates that even
among patients seeking health care mainly for one symp-
tom of the kind discussed here, it is important to check
for multiple stress-related symptoms, thereby increasing
the possibility of preventing the development of more
severe stress-related conditions such as exhaustion.
An improvement regarding most symptoms with time,
similar for both sexes and age groups was shown. No
specific treatment was offered for the single somatic
symptoms. All patients received individualised MMT
mainly including measures to reduce stress exposure. As
this study is not designed as an intervention study, we
cannot conclude whether the MMT treatment offered at
the clinic is responsible for the improvement in somatic
symptom. We can thus only cautiously conclude that
the treatment offered seems to offer general stress re-
duction and probable effects of stress-related symptoms
in general. A substantial improvement the first three
months after the initial visit at the clinic was shown.
This early reduction in symptoms could be an effect of
the initial consultation offering support and care. This
brings about relief of worries, as do the offers of sick
leave or various rehabilitation activities. The general aim
of the treatment programme at the clinic is reduce both
the stress exposure and the perceived stress levels and it
is likely that this is having an effect on both mental and
somatic symptoms.
Even though the prevalence of most symptoms grad-
ually decreases, one fifth of the patients were still report-
ing six symptoms or more at the 18-month follow-up.This reduction of symptoms seems, however, to be
greater for patients with ED than for patients with soma-
tisation, as about 18 per cent of the patients in this study
reported six symptoms or more after 12 months com-
pared to around half of the participants in a study of fe-
male patients with somatisation [50]. We can cautiously
conclude that patients with ED seem to differ from
patients with somatisation and the core problem for the
ED-patients is the mental exhaustion. The somatic
symptoms that co-exist with that exhaustion seem to be
mainly stress-related which gradually decrease with time
as the patient is being treated for the stress problems.
The only exception in regard to reduction of symptoms
during MMT treatment is pain in arms, legs and joints,
reported by around half of the patients, both men and
women. This problem is more pronounced in older pa-
tients with stress-related exhaustion. The prevalence does
not change significantly over time and this is one of the
most common symptoms reported by both men and
women during the 18-month follow-up. Thus, such local-
ised pain problems are not relieved concomitantly as
the patients are being treated for the stress problems.
This is an interesting finding as multimodal treatment
programme directed towards pain has been shown to
be successful, at least in patients seeking medical care
predominantly for musculoskeletal pain problems [51].
Thus, it seems that the MMT used in our clinic, tai-
lored to relieve the mental symptoms but also having a
positive effect on most of the somatic symptoms
should be supplemented with additional modalities in
cases with pronounced localised pain. Such an approach
should be considered early in the treatment of this type of
patient. Our finding regarding lack of improvement in
musculoskeletal symptoms in patients with mental health
problems is not unique as several previous studies have
reported similar results. In a review 2003, it was shown
that patients with both depression and pain experienced
longer duration of pain and poorer overall response to
treatment than patients experiencing pain without co-
morbid depression [52]. A study of patients with depres-
sion randomly assigned to care as usual or to one of two
collaborative management programmes showed that pa-
tients randomised to the intervention group reported sig-
nificantly fewer somatic symptoms at follow-up except for
current pain symptoms [53]. The majority of the patients
in this study suffered from co-morbid depression at base-
line which might have contributed to the large proportion
still reporting pain at the final follow-up. Additional ana-
lysis also showed that this group scored significantly
higher on symptoms of depression, but not on symptoms
of burnout, compared to those without pain, which con-
firms previous research showing that patients reporting
both depression and pain symptoms experience a longer
duration of pain problems [52].
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symptoms could be predicted by factors that could be of
importance for the course of illness. Interestingly, co-
morbid depression or anxiety, sick leave and physical
activity did not predict the decrease of somatic symptoms
in patients with multiple symptoms at baseline in our
study. This is different to what has previously been shown
regarding the development of persistent somatisation, i.e.
that anxiety, depression, marked impairment, and older
age are predictors, according to a review by Creed and
Barsky [54]. Symptom duration was the only factor found
to predict recovery from mental symptoms in our previ-
ous study of the same patient group [8].
The course of improvement of somatic symptoms in
patient with stress-related mental exhaustion as a core
feature seems to be more related to the stress reduction
than to factors that otherwise might predict recovery, e.g.
in patients with somatisation, when the somatic symptoms
are the core feature.
There are several limitations that should be mentioned
regarding this study. Firstly, this is not an intervention
study and the purpose is not to relate treatment to
symptoms as all patients received similar treatment. We
can thus not make a firm conclusions that the treatment
offered at the clinic is solely responsible for the reduc-
tion in somatic symptoms reported by the patients. An-
other important limitation is that the referral procedure
has resulted in a selection of a patient population that is
quite highly educated with presumably high health liter-
acy and knowledge of the possibilities and usability of
the health care system. Thus, the results are not easy to
generalise to other groups. To ensure that the study
group is reasonably homogeneous with regard to dur-
ation of symptoms and sick leave, only data from pa-
tients reporting sick leave shorter than six months was
analysed in this study. The treatments that had been
undertaken prior to the consultation at the stress clinic
varied somewhat, especially regarding AD medication.
We did not find any difference between patients with
and without ADs in the recovery, either with regard to
mental or somatic symptoms in this study. Another limi-
tation is that the content of the MMT at the stress clinic
could differ somewhat between the patients due to indi-
vidual needs, but we have no reason to believe that this
constitutes any major bias in this study when comparing
different groups i.e. men and women or younger and
older patients. It should also be mentioned that the som-
atic symptoms were measured using a symptom check-
list and no measure of severity was performed. A
symptom checklist like the PRIME MD that simply in-
quires about the presence or absence of a symptom may
overestimate clinically relevant symptoms. Finally, ques-
tions could be raised with regard to common method
variance as a limitation. Physical symptoms are includedin the ED diagnosis as one of six items under criterion
C. However, only four out of six items on C have to be
answered positive for an ED diagnosis. Thus, reporting
somatic symptoms are possible but not obligatory in
order to be diagnosed with ED. Since patients with
stress-related exhaustion without any such symptoms
still can meet the diagnostic criteria it does not seem
plausible that the prevalences of somatic symptoms are
overestimated.
The major strength of this study is that it comprises a
large number of patients from the same clinic, diagnosed
and treated by only three different senior physicians. A
long-term follow-up of 18 months is studied. To our
knowledge this is the first study presenting the preva-
lence and course of somatic symptoms in a clinical
patient population with mental exhaustion/burnout.Conclusion
In conclusion, this study provides important knowledge
regarding somatic symptoms in patients with stress-
related exhaustion. The prevalence and course of symp-
toms were not related to sex or age. Somatic symptoms
were strongly related to mental symptoms at baseline
but, interestingly, co-morbid depression or anxiety did
not predict recovery of somatic symptoms. Most of the
symptoms seem to be stress-related and concomitantly
with that the patients are being treated for the stress-
related exhaustion, reduced prevalence is seen for almost
all somatic symptoms. One important exception is pain
in the arms, legs and joints which were highly prevalent
still after 18 months. Thus, special attention should be
paid to such symptoms especially in older patients. This
study points out the importance of acknowledging the
large number of somatic symptoms often present in
these patients, without overlooking the core problems of
exhaustion and co-morbid mental health symptoms such
as depression and anxiety.
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